<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d428">
    <sentence id="DDI-DrugBank.d428.s0" text="ELLENCE when used in combination with other cytotoxic drugs may show on-treatment additive toxicity, especially hematologic and gastrointestinal effects.">
        <entity id="DDI-DrugBank.d428.s0.e0" charOffset="0-6"
            type="brand" text="ELLENCE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s1" text="Concomitant use of ELLENCE with other cardioactive compounds that could cause heart failure (e.g., calcium channel blockers), requires close monitoring of cardiac function throughout treatment.">
        <entity id="DDI-DrugBank.d428.s1.e0" charOffset="19-25"
            type="brand" text="ELLENCE"/>
        <entity id="DDI-DrugBank.d428.s1.e1" charOffset="99-122"
            type="group" text="calcium channel blockers"/>
        <pair id="DDI-DrugBank.d428.s1.p0" e1="DDI-DrugBank.d428.s1.e0"
            e2="DDI-DrugBank.d428.s1.e1" ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s2" text="There are few data regarding the coadministration of radiation therapy and epirubicin.">
        <entity id="DDI-DrugBank.d428.s2.e0" charOffset="75-84"
            type="drug" text="epirubicin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s3" text="In adjuvant trials of epirubicin-containing CEF-120 or FEC-100 chemotherapies, breast irradiation was delayed until after chemotherapy was completed.">
        <entity id="DDI-DrugBank.d428.s3.e0" charOffset="22-31"
            type="drug" text="epirubicin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s4" text="This practice resulted in no apparent increase in local breast cancer recurrence relative to published accounts in the literature."/>
    <sentence id="DDI-DrugBank.d428.s5" text="A small number of patients received epirubicin-based chemotherapy concomitantly with radiation therapy but had chemotherapy interrupted in order to avoid potential overlapping toxicities.">
        <entity id="DDI-DrugBank.d428.s5.e0" charOffset="36-45"
            type="drug" text="epirubicin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s6" text="It is likely that use of epirubicin with radiotherapy may sensitize tissues to the cytotoxic actions of irradiation.">
        <entity id="DDI-DrugBank.d428.s6.e0" charOffset="25-34"
            type="drug" text="epirubicin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s7" text="Administration of ELLENCE after previous radiation therapy may induce an inflammatory recall reaction at the site of the irradiation.">
        <entity id="DDI-DrugBank.d428.s7.e0" charOffset="18-24"
            type="brand" text="ELLENCE"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s8" text="Epirubicin is extensively metabolized by the liver.">
        <entity id="DDI-DrugBank.d428.s8.e0" charOffset="0-9"
            type="drug" text="Epirubicin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s9" text="Changes in hepatic function induced by concomitant therapies may affect epirubicin metabolism, pharmacokinetics, therapeutic efficacy, and/or toxicity.">
        <entity id="DDI-DrugBank.d428.s9.e0" charOffset="72-81"
            type="drug" text="epirubicin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s10" text="Cimetidine increased the AUC of epirubicin by 50%.">
        <entity id="DDI-DrugBank.d428.s10.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d428.s10.e1" charOffset="32-41"
            type="drug" text="epirubicin"/>
        <pair id="DDI-DrugBank.d428.s10.p0"
            e1="DDI-DrugBank.d428.s10.e0" e2="DDI-DrugBank.d428.s10.e1"
            ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s11" text="Cimetidine treatment should be stopped during treatment with ELLENCE.">
        <entity id="DDI-DrugBank.d428.s11.e0" charOffset="0-9"
            type="drug" text="Cimetidine"/>
        <entity id="DDI-DrugBank.d428.s11.e1" charOffset="61-67"
            type="brand" text="ELLENCE"/>
        <pair id="DDI-DrugBank.d428.s11.p0"
            e1="DDI-DrugBank.d428.s11.e0" e2="DDI-DrugBank.d428.s11.e1"
            ddi="true" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d428.s12" text="Drug-Laboratory Test Interactions There are no known interactions between ELLENCE and laboratory tests.">
        <entity id="DDI-DrugBank.d428.s12.e0" charOffset="74-80"
            type="brand" text="ELLENCE"/>
    </sentence>
</document>
